Champions Oncology (NASDAQ:CSBR) opened at $3.91 on Wednesday. Champions Oncology has a 1-year low of $2.19 and a 1-year high of $4.75.
Separately, ValuEngine cut shares of Champions Oncology from a “hold” rating to a “sell” rating in a report on Wednesday, December 6th.
TRADEMARK VIOLATION NOTICE: “Champions Oncology (CSBR) Set to Announce Earnings on Thursday” was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.thelincolnianonline.com/2018/03/14/champions-oncology-csbr-set-to-announce-earnings-on-thursday.html.
Champions Oncology Company Profile
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology and related companies with MarketBeat.com's FREE daily email newsletter.